Increased mortality in patients with diabetes associated with olmesartan for the prevention/delay of microalbuminuria onset: a matter of concern?

MeSH terms

• Aged
• Albuminuria / drug therapy*
• Albuminuria / etiology
• Angiotensin II Type 1 Receptor Blockers / adverse effects*
• Angiotensin II Type 1 Receptor Blockers / therapeutic use*
• Diabetes Mellitus, Type 2 / complications
• Diabetes Mellitus, Type 2 / mortality*
• Diabetic Cardiomyopathies / drug therapy*
• Female
• Humans
• Imidazoles / adverse effects*
• Imidazoles / therapeutic use*
• Male
• Middle Aged
• Randomized Controlled Trials as Topic
• Risk Assessment
• Tetrazoles / adverse effects*
• Tetrazoles / therapeutic use*